News | November 13, 2008

MP3 Headphones Interfere with Implantable Defibrillators, Pacemakers

November 14, 2008 - Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators (ICDs) may interfere with these devices, according to research presented this week at the American Heart Association's Scientific Sessions 2008 in New Orleans.

Researchers investigated the effects of MP3 digital music player headphones, most of which contain the magnetic substance neodymium, on the operation of implanted cardiac devices. Earlier this year an FDA report concluded that interactions between MP3 players, such as the popular iPod, and implanted cardiac devices are unlikely to occur.

"We became interested in knowing whether the headphones which contain magnets - not the MP3 players, themselves - would interact with implanted cardiac devices," said William H. Maisel, M.D., MPH, senior author of the study and director of the Medical Device Safety Institute at Beth Israel Medical Center in Boston, MA.

Maisel said doctors traditionally use magnets in the clinical setting to test pacemakers, which treat slow heart rhythms. When exposed to magnets, these devices automatically pace, sending low-energy signals to the heart to make it beat. Defibrillators, which treat slow and dangerously fast heart rhythms, send either low- or high-energy signals to the heart. However, ICDs near magnets may temporarily stop looking for abnormal heart rhythms, researchers said.

Implanted cardiac devices that react in these ways to magnets outside the clinical setting can be potentially dangerous for patients who rely on their lifesaving technologies.

Researchers tested eight different models of MP3 player headphones (including both the clip-on and earbud variety) with iPods on 60 defibrillator and pacemaker patients.

"We placed the headphones on the patients' chests, directly over where their devices are located, monitoring them for evidence of an interaction," Dr. Maisel said.

The researchers found a detectable interference with the device by the headphones in 14 patients, (23 percent). Specifically, they observed that 15 percent of the pacemaker patients and 30 percent of the defibrillator patients had a magnet response, Dr. Maisel said.

"For patients with pacemakers, exposure to the headphones can force the device to deliver signals to the heart, causing it to beat without regard to the patients' underlying heart rhythm," he said. "Exposure of a defibrillator to the headphones can temporarily deactivate the defibrillator." In most cases, he said removal of the headphones restores normal device function.

The researchers also tested the magnetic field strengths of each of the headphone models using a gauss meter, which measures the units of magnetic charge produced.

Field strength of 10 gauss at the site of the pacemaker or defibrillator has the potential to interact with the implantable device. The researchers found that some of the headphones had field strengths as high as 200 gauss or more.

"Even at those high levels, we did not observe any interactions when the headphones were at least 3 cm, or about 1.2 inches, from the skin's surface," Dr. Maisel said. "Patients should not focus on the brands we tested, but instead should simply be instructed to keep their headphones at least 3 cm from their implantable devices."

Instead, researchers said patients should not place headphones in their pocket or drape them over their chest.

"For family members or friends of patients with implantable defibrillators, they should avoid wearing headphones and resting their head right on top of someone's device," he said.

In two unrelated studies, researchers did not report adverse heart-related effects on implantable cardiac devices from other devices.

Researchers in Hyannis, MA, found that cell phones equipped with wireless technology known as Bluetooth and pills swallowed to view internal organs are unlikely to interfere with pacemakers or ICDs.

Likewise, California researchers determined that electromagnetic interference from personal devices including iPod, iPod nano, iPhone, some cell phones (with and without Bluetooth technology), electric blankets, and hand-held airport security metal detectors did not cause adverse effects to patients with pacemakers or ICD.

For more information: www.americanheart.org

Related Content

New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
Overlay Init